Eli Lilly: In type 2 diabetes trials, Orforglipron outperforms Semaglutide in both blood sugar control and weight loss.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Glonghui, February 26th｜Eli Lilly stated that in type 2 diabetes trials, its oral GLP-1 drug Orforglipron outperformed Novo Nordisk's oral semaglutide in both blood sugar control and weight loss. Applications for Orforglipron have been submitted to regulatory agencies in more than 40 countries, and the company expects to initiate the obesity indication approval process in the United States in the second quarter of 2026.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
SUI Price Reclaims $1 as Analysts Watch $1.50 Resistance
CoinCryptoNewz•2026/09/26 05:57
Smart ring manufacturer Oura (OURA.US) IPO reportedly oversubscribed by about 4 times
According to market sources, the initial public offering (IPO) of smart ring manufacturer Oura in the US stock market has reportedly been oversubscribed by approximately four times.
智通财经•2026/09/26 03:46
NEAR Protocol Price Surges Above $5 as Breakout Momentum Builds
CoinCryptoNewz•2026/09/26 03:15
Crypto prices
More
Bitcoin
BTC
$83,904.51
-0.35%
Ethereum
ETH
$2,685.34
+0.21%
Tether USDt
USDT
$0.9998
+0.02%
BNB
BNB
$772.56
-0.24%
XRP
XRP
$1.55
+1.10%
USDC
USDC
$0.9999
+0.02%
Solana
SOL
$120.37
+3.27%
TRON
TRX
$0.3372
-0.39%
Zcash
ZEC
$1,531.92
-0.92%
Hyperliquid
HYPE
$91.56
-0.50%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now